CIVB · Insider Trading
Civista Bancshares, Inc.
Every open-market purchase and sale reported by CIVB officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Charles A. Parcher | President | Buy | +400 | +$10.70K |
| 2026-08-07 | Veronica G Doucette | SVP/Human Resources Officer | D | −528 | −$15.03K |
| 2026-08-07 | Veronica G Doucette | SVP/Human Resources Officer | D | −528 | −$15.03K |
| 2026-07-29 | Mark J. Macioce | Director | D | −57 | −$1.70K |
| 2026-06-10 | Lorina W Wise | Director | A | +1,210 | — |
| 2026-06-10 | Julie A Mattlin | Director | A | +1,210 | — |
| 2026-06-10 | Mary Patricia Oliver | Director | MIXED | +1,321 | — |
| 2026-06-10 | Harry Singer | Director | MIXED | +1,347 | — |
| 2026-06-10 | Mark J. Macioce | Director | MIXED | +1,253 | — |
| 2026-06-10 | Nathan E Weaks | — | A | +1,210 | — |
| 2026-06-10 | Clyde A Perfect Jr | — | A | +1,210 | — |
| 2026-06-10 | Darci L Congrove | Director | A | +1,210 | — |
| 2026-06-10 | Gerald B Wurm | — | MIXED | +3,326 | — |
| 2026-04-01 | Veronica G Doucette | SVP/Human Resources Officer | A | +908 | — |
| 2026-03-13 | Ian Whinnem | SVP/CFO | A | +2,313 | — |
| 2026-03-13 | Lance A. Morrison | SVP, Legal Counsel | MIXED | +1,117 | — |
| 2026-03-13 | Richard J Dutton | Senior Vice President | MIXED | +1,606 | — |
| 2026-03-13 | Dennis G Shaffer | CEO | MIXED | +6,553 | — |
| 2026-03-13 | Charles A. Parcher | President | MIXED | +4,513 | — |
| 2026-03-13 | Robert L Curry Jr | Senior Vice President | MIXED | +979 | — |
| 2026-03-13 | Carl A Kessler III | Senior Vice President | MIXED | +1,147 | — |
| 2026-03-13 | Russell L Edwards Jr | Senior Vice President | MIXED | +784 | — |
| 2026-03-13 | Michael D. Mulford | Senior Vice President | A | +1,361 | — |
| 2026-03-13 | Robert L Katitus | SVP/CLO | MIXED | +1,018 | — |
| 2026-03-13 | Donna M. Waltz-Jaskolski | Senior Vice President | MIXED | +851 | — |
| 2025-11-19 | Nathan E Weaks | — | Buy | +1,000 | +$21.49K |
| 2025-08-21 | Nathan E Weaks | — | Buy | +500 | +$9.93K |
| 2025-08-19 | Nathan E Weaks | — | Buy | +500 | +$9.97K |
| 2025-08-05 | Ian Whinnem | SVP/CFO | Buy | +1,500 | +$28.80K |
| 2025-07-31 | Nathan E Weaks | — | Buy | +3,000 | +$59.11K |
| 2025-07-15 | Dennis G Shaffer | CEO and President | Buy | +1,000 | +$21.25K |
| 2025-07-15 | Michael D. Mulford | Senior Vice President | Buy | +1,000 | +$21.25K |
| 2025-07-15 | Lance A. Morrison | SVP, Legal Counsel | Buy | +1,000 | +$21.25K |
| 2025-07-15 | Darci L Congrove | Director | Buy | +1,250 | +$26.56K |
| 2025-07-15 | Richard J Dutton | Senior Vice President | Buy | +4,000 | +$85.00K |
| 2025-07-15 | Clyde A Perfect Jr | — | Buy | +2,352 | +$49.98K |
| 2025-07-15 | Mark J. Macioce | Director | Buy | +640 | +$13.60K |
| 2025-07-15 | Charles A. Parcher | Senior Vice President | Buy | +1,000 | +$21.25K |
| 2025-05-14 | Lorina W Wise | Director | A | +1,027 | — |
| 2025-05-14 | Mark J. Macioce | Director | MIXED | +1,040 | — |
| 2025-05-14 | Julie A Mattlin | Director | A | +1,027 | — |
| 2025-05-14 | Harry Singer | Director | MIXED | +1,148 | — |
| 2025-05-14 | Clyde A Perfect Jr | — | A | +1,027 | — |
| 2025-05-14 | Nathan E Weaks | — | A | +1,027 | — |
| 2025-05-14 | Gerald B Wurm | — | A | +3,159 | — |
| 2025-05-14 | Dennis E Murray Jr | Director | MIXED | +1,089 | — |
| 2025-05-14 | Darci L Congrove | Director | A | +1,027 | — |
| 2025-05-14 | Mary Patricia Oliver | Director | MIXED | +1,123 | — |
| 2025-04-30 | Dennis E Murray Jr | Director | MIXED | +62 | +$1.15K |
| 2025-03-13 | Lance A. Morrison | SVP, Legal Counsel | MIXED | +657 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Dennis G Shaffer | CEO | 52,547 | $1.41M |
| Gerald B Wurm | — | 46,515 | $1.24M |
| Richard J Dutton | Senior Vice President | 29,583 | $791.35K |
| Charles A. Parcher | President | 28,979 | $775.19K |
| Dennis E Murray Jr | Director | 24,546 | $656.63K |
| Nathan E Weaks | — | 15,832 | $423.51K |
| Julie A Mattlin | Director | 14,679 | $392.66K |
| Harry Singer | Director | 14,311 | $382.83K |
| Robert L Katitus | SVP/CLO | 8,463 | $226.39K |
| Mary Patricia Oliver | Director | 7,641 | $204.41K |
| Carl A Kessler III | Senior Vice President | 7,248 | $193.88K |
| Ian Whinnem | SVP/CFO | 6,067 | $162.29K |
| Lance A. Morrison | SVP, Legal Counsel | 5,548 | $148.41K |
| Clyde A Perfect Jr | — | 4,885 | $130.67K |
| Donna M. Waltz-Jaskolski | Senior Vice President | 4,868 | $130.23K |
| Darci L Congrove | Director | 4,862 | $130.06K |
| Russell L Edwards Jr | Senior Vice President | 4,855 | $129.87K |
| Lorina W Wise | Director | 4,549 | $121.69K |
| Mark J. Macioce | Director | 4,217 | $112.82K |
| Michael D. Mulford | Senior Vice President | 2,365 | $63.26K |
| Robert L Curry Jr | Senior Vice President | 2,360 | $63.15K |
| Veronica G Doucette | SVP/Human Resources Officer | 1,175 | $31.43K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CIVB quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.